hotspot -WSS

hotspot

author：fashion 2025-09-06 04:14:08 - browse：1437

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： European officials brace for rough respiratory virus season

WSS

CDC picks Alphabet's Verily for wasterwater surveillance contract

CDC picks Alphabet's Verily for wasterwater surveillance contract

Will an HIV vaccine ever be a reality?

Stop Congress from blocking public access to science

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Setback for rare diseases as Taysha Gene Therapies pulls back

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Psychedelics group wrestles with new pharma identity

IVG is promising — but it won’t replace IVF quite yet

Dobbs anniversary: the lost opportunity of abortion as health care

Couple fighting to bring baby home from Mexico are finally reunited

Affirmative action in medical school literally saved lives

How dance can help health care workers heal from trauma

Peter Hotez and the public health issue of online harassment

How dance can help health care workers heal from trauma

Hollywood unions extend contract negotiations for actors

Couple fighting to bring baby home from Mexico are finally reunited

entertainment

Some top drug companies are starting to take action on climate

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Ebola public health emergency is over, WHO declares

Study points to new risk in gene therapy death of Terry Horgan

Couple fighting to bring baby home from Mexico are finally reunited

What we owe ALS patients — and why one company fell short

focus

focus

entertainment

explore